v0.24.1

Fixed

• Idempotency fingerprint now includes the execution params (allocation,
  rebalance-scope, sweep, threshold, threshold-mode, whole-shares, min-weight),
  not just broker/account/targets. Before, a deliberate second same-day run that
  changed how the book is executed (e.g. --rebalance-scope per-ticker,
  --no-sweep, a different --allocation) hashed identically to the first and
  was silently skipped as a duplicate. Such a run is a different plan and now
  executes. Same-plan re-runs still dedupe; --force still overrides.
• Post-trade verify is now buying-power-aware under --margin-aware. A fully
  invested / margin-limited book no longer reports "🔴 NOT converged" for a
  residual buy it cannot fund, and self-heal no longer re-submits unaffordable
  buys every pass. A residual buy that can't be funded from buying power (+ any
  residual sell proceeds) is treated as converged (the book is as-deployed-as
  -possible) and removed so self-heal skips it; an affordable residual buy still
  flags non-convergence, and a failed close (residual SELL) is never excused.

Audit

• Production-readiness sweep of the execution path found no critical
  sign/rounding/double-execution bugs; the core sizing math is sound. Remaining
  open items (broker-adapter stop round-trip specifics for Schwab/Tradier/
  Hyperliquid) need live-API confirmation and are tracked separately.

What's Changed

• fix: production-readiness audit fixes — idempotency fingerprint + buying-power-aware verify (0.24.1) by @markudevelop in #6

Full Changelog: v0.24.0...v0.24.1